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1740 Abstracts December 2013antegrade approach. Routine anticoagulation and dual-antiplatelet therapy
was used peri-procedurally. Antegrade access was used to treat any lesion
that required a stent placement, after the retrograde wire was snared and
brought through the antegrade guide catheter. Patient indications and
comorbidities were recorded; outcomes analyzed were limb salvage rate,
peri-procedural complications and mortality. Mean and standard deviations
were calculated; Kaplan-Meier was used to calculate limb salvage rates.
Results: A review all lower extremity interventional angiograms from
July 2010 thru August 2013 (n ¼ 764) identiﬁed 13 cases in which a retro-
grade pedal access was performed (mean age was 71.46 12.4 years, 9 men).
There was high prevalence of diabetes (77%; 10/13), chronic renal insufﬁ-
ciency (stages III - V; 69%, 9/13), and previous contralateral major ampu-
tation (38%; 5/13). Indications for a retrograde pedal revascularization
were Rutherford chronic limb ischemia class IV (15%; 2/13) and class V
(85%; 11/13). Technical success rate was 69% (9/13); a variety of popliteal
(2/13) and tibial (13/13) vessels were intervened with angioplasty alone
(10/13) via a retrograde approach and with angioplasty/stent placement
(3/13). The technical failures were due to inability to cross the occlusion(s).
Periprocedurally, there was one myocardial infarction, no local complica-
tions, worsening renal insufﬁciency or deaths. At a mean follow-up of
13.4 6 10.3 months, the limb salvage rate was 77% (10/13) (Fig). There
was a high mortality rate on follow-up in this cohort (23%; 3/13) occurring
at median 6 6 4 months.
Conclusions: Retrograde pedal access for limb salvage in high-risk
patients is feasible and safe with acceptable limb salvage rates at intermediate
follow-up. Appropriate candidates are those who have failed an antegrade
intervention and are poor candidates for a tibial bypass. Future studies
should test whether this mode of revascularization has favorable limb
salvage rates in larger patient populations.
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Objectives: Endovenous ablation of the saphenous vein (EVLT) has
become the preferred treatment for treating saphenous reﬂux, which results
in symptomatic lower extremity venous insufﬁciency or varicose veins. This
ofﬁce-based ambulatory procedure was noted during initial Food and Drug
Administration trials to have a low incidence of postoperative deep vein
thrombosis (DVT). Later clinical experience suggested that the actual inci-
dence of DVT may be much higher.
Methods: We reviewed the ofﬁce records and the pre- and post-treat-
ment ultrasounds of patients undergoing EVLT in our ofﬁce from 2005 to
2010 to determine the frequency of postoperative DVT in patients we had
treated and then graded them according to a previously published
classiﬁcation.
Results: There were 528 veins treated in 192 males and 336 females.
The CEAP class for these patients was 1 (0), 2 (291), 3 (65), 4 (104), 5
(26), and 6 (40). The greater saphenous vein was treated in 496, the lesser
saphenous vein (LSV) in 22 and both were treated in 10. DVT occurred in
27 of legs treated for an incidence of 5.1%. The DVTs in the femoral veinwere of level 3 (3), 4 (7), 5 (12), and 6 (3). Two patients developed
DVT in the popliteal vein after EVLT of the LSV. Treatment for the postop
DVT consisted of observation (13), anticoagulation (9), antiplatelet therapy
(2), and nonsteroidal anti-inﬂammatory agents (1). Duration of therapy was
usually 1 week but seven patients were treated for periods ranging from 1 to
7 weeks. No pulmonary emboli occurred in any of these patients. The DVTs
resolved completely in all patients.
Conclusions: The incidence of DVT after EVLT is higher than previ-
ously reported but is not associated with pulmonary embolism and mainly
consists of low risk level 3, 4, and 5 DVT. The DVT typically resolves after
1 week and can be treated with a short course of antiplatelet or anticoagu-
lation therapy although observation appears to be sufﬁcient as well.
Thoracic Endovascular Aortic Repair for Intramural Hematoma: Safe
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Objectives: Intramural hematoma (IMH), penetrating aortic ulcer
(PAU), and aortic dissection comprise a spectrum of acute aortic patholo-
gies. While thoracic endovascular aortic repair (TEVAR) has increasingly
been applied to aortic dissection, there is a paucity of data on the impact
of TEVAR for IMH on aortic anatomy. Our goal was to investigate the
extent of aortic remodeling after TEVAR for IMH.
Methods: A retrospective chart review of patients from 2004 to 2012
was conducted on patients with IMH with or without PAU. Charts were
reviewed in a retrospective manner to collect data detailing: demographics,
indications for surgery, operative notes, and ofﬁce progress notes. Radiology
images were reviewed and primary data points included indices of the aortic
true lumen (TL) and total aortic diameter at site of pathology (TAD).
Aortic remodeling was evidenced by a TAD/TL ratio closest to 1.0.
Patients with no preoperative computed tomography (CT) scan, or no
imaging after 30 days of operation were not included for imaging analysis.
Results: During our 8-year period, 216 endovascular thoracic aortic
repairs were reviewed. Forty-eight patients were found to have an IMH on
presentation for repair; 25 of the 48 patients had an IMH with concomi-
tant PAU. Of the total cohort, 18 were male with a mean age of 70.2 years
6 10 (standard deviation).Forty-six (96%) of patients had diagnoses of
hypertension, 34 (71%) were smokers, and 7 (19%) had coronary artery
disease or prior myocardial infarction. Indications for operation included
intractable pain in 34 (69%), uncontrolled hypertension in six (13%) and
rupture in eight (17%). Technically successful TEVAR was performed in
all patients with 45 (94%) reporting relief of symptoms post procedure.
Adjunctive procedures were performed in 19 (40%): 7 (14%) arch
debranching, 6 (12%) laser fenestration, and 6 (12%) iliac conduit. Post
procedurally, the 30 day mortality rate was 6% with a 4% rate of permanent
paraplegia. At a mean follow-up of 11.6 months, the overall survival was
69% with a reintervention rate of 12%. For our imaging analysis, 12
patients were excluded due to lack of follow-up imaging after 30 days
resulting in the analysis of 36 CT scans. Imaging revealed that the preop-
erative ratio of TAD/TL was 1.33 6 0.13. The mean number of days to
follow-up CT was 383 days with a range of 48 to 1486 days. There was
a signiﬁcant decrease in the postoperative TAD/TL ratio to 1.10 6 0.10
(vs preoperative TAD/TL ratio; P < .001). 3 (8%) patients had subsequent
repeat TEVAR procedure either due to proximal endoleak or graft migra-
tion. The mean change in TAD/TL ratio from pre to postoperative for
the reinterventions was 0.14, while the mean change in TAD/TL ratio
from pre to postoperative for the nonreinterventions was 0.27 (P < .001).
Conclusions: Although more longitudinal studies are necessary,
endograft therapies for IMH, when anatomically possible, promote aortic
remodeling, and potentially, complete long-term resolution.
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Objectives: As the management of peripheral vascular disease (PVD)
evolves, it is important that we determine what factors affect the outcome of
lower extremity interventions. The presence of PVD is associated with
a twofold increase in the prevalence of congestive heart failure (CHF),
and it is well known that patients with CHF are at risk for perioperative
complications. It was recently demonstrated that CHF is associated with
reduced patency after endovascular intervention for PVD at 1 year.
However, the impact of CHF on patients undergoing infrainguinal bypass
for PVD has not been extensively studied. The goal of this study is to
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Methods: The study group consisted of all patients entered in
a prospective, multicenter database (ACS-NSQIP) undergoing infrainguinal
bypass from 2005 to 2010 (n ¼ 30,596). Patients with CHF within 30 days
prior to surgery (n ¼ 899) were compared with those without a CHF diag-
nosis (n ¼ 29,697). Thirty-day graft patency, morbidity, and mortality were
compared between groups using a multivariate logistic regression analysis
controlling for covariates.
Results: Infrainguinal bypass graft failure was not signiﬁcantly
different for patients with CHF (4.9%) vs those without (4.5%; P ¼ .55).
There was no difference in patency for femoral-popliteal grafts (No CHF
96.3%, CHF 96.1%; P ¼ .86) nor femoral-tibial grafts (No CHF 91.8%,
CHF 89.3%; P ¼ .2). The variables of CHF and loss of patency had no
signiﬁcant association (phi ¼ 0.003). The prediction model for postopera-
tive pneumonia was signiﬁcant (P < .0001) with prediction accuracy (c ¼
0.71). CHF was associated with 71% higher odds of postoperativepneumonia compared with those without CHF (odds ratio [OR] 1.71;
95% conﬁdence interval [CI], 1.26-2.31; P ¼ .0005) after correction for
covariates. CHF was also associated with pulmonary embolism after
accounting for covariates with CHF increasing the odds of pulmonary
embolism threefold (OR, 2.91; 95% CI, 1.19-7.07; P ¼ .02). CHF was
independently associated with a 41% increase in the odds of prolonged intu-
bation (OR,1.41; 95% CI, 1.07-1.85; P ¼ .014) and a 65% increase in re-
intubation (OR, 1.65; 95% CI,1.24-2.19; P ¼ .0006). There was a trend
toward an increased incidence of cardiac arrest (P ¼ .09), and a signiﬁcant
association with 30-day mortality (OR, 1.90; 95% CI, 1.52-2.38; P <
.0001).
Conclusions: A history of CHF does not impact acute infrainguinal
bypass graft patency. However, it does increase the complication rate of peri-
operative pneumonia, pulmonary embolism, prolonged intubation, reintuba-
tion, and mortality. Therefore, lower extremity intervention in patients with
a history of CHF should incorporate an individualized approach to optimize
success of the revascularization while minimizing medical comorbidities.
